Company news
Herantis Pharma PLC news in 2025
Herantis Pharma PLC's news releases, calls and decks from 2025, newest first.
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
November 26, 2025
Herantis Pharma presents positive topline data for HER-096 in Phase 1b trial for people living with Parkinson’s disease
October 7, 2025
Herantis Pharma releases 1H 2025 report today
August 21, 2025
Last patient visit completed on schedule in Phase 1b clinical trial of HER-096 for Parkinson’s disease
August 14, 2025
Herantis Pharma: Plc's board decides on new option rights program for managing director, management team and other key personnel
May 23, 2025
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
May 13, 2025
Decisions of Herantis Pharma Plc's Annual General Meeting of shareholders and constitutive meeting of the Board of Directors
April 23, 2025